Oncology medicines in Canada : trends and international comparisons, 2010-2019.: H82-51/2020E-PDF
"Oncology medicines are an increasingly important driver of Canadian pharmaceutical sales. Over the past decade, this significant segment has doubled its share of the market, now accounting for $3.9 billion in sales nationally. … This analysis provides an overview of the Canadian prescription oncology market from 2010 to 2019. The chartbook is divided into three sections: the first explores the dynamics of the international market for oncology medicines; the second takes a closer look at oncology sales, market distribution, and treatment costs in Canada; and the third examines these trends in the context of Canada's private drug plans"--Introduction, page 5.
Permanent link to this Catalogue record:
|Department/Agency||Canada. Patented Medicine Prices Review Board, issuing body.|
|Title||Oncology medicines in Canada : trends and international comparisons, 2010-2019.|
|Other language editions||[French]|
|Note(s)|| Issued also in French under title: Les médicaments oncologiques au Canada : tendances et comparaisons internationales, 2010-2019. |
Issued also in HTML format.
Includes bibliographical references.
|Publishing information|| Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2020. |
|Description||1 online resource (32 pages) : colour illustrations|
|Catalogue number|| |
|Subject terms|| Antineoplastic agents -- Canada -- Statistics. |
Antineoplastic agents -- Statistics.
Antineoplastic agents -- Prices -- Canada -- Statistics.
Antineoplastic agents -- Prices -- Statistics.
Request alternate formatsTo request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
- Date modified: